To investigate the prognostic influence on long-term overall survival (OS) from treatment with Chinese medicine (CM) and chemotherapy or targeted therapy in advanced non-small-cell lung cancer (NSCLC) patients. The clinical data of 206 advanced NSCLC patients who were treated with CM and Western medicine in Beijing Cancer Hospital from April 1999 to July 2013 were retrospectively analyzed. Long-term survivors were defined as OS a (c) 3/4 3 years after treatment with CM and chemotherapy. Twenty-eight patients had OS a (c) 3/4 3 years, 178 had OS < 3 years, and all clinical data were statistically analyzed with the Cox model. Variables were gender, age, smoking status, performance status (PS) score, pathological type, clinical stage, fi...
Background and objective It has been proven that gefitinib produces only 10%-20% tumor regression in...
Background and objective Non-small cell lung cancer (NSCLC) stages over IIIb still remain as an intr...
Objective. Novel therapeutics and supportive care improved outcomes for metastatic non-small-cell lu...
Purpose. Many patients with advanced non-small-cell lung cancer (NSCLC) seek help from Chinese herba...
[[abstract]]Objectives: The study aim was to compare the long-term effect of Western medicine and co...
Purpose: Many patients with advanced non-small-cell lung cancer (NSCLC) seek help from Chinese herba...
Lung cancer has become the leading cause of cancer deaths, with nonsmall cell lung cancer (NSCLC) ac...
Objective. This study was designed to evaluate the clinical efficacy of combined traditional Chinese...
Objective: To evaluate the efficacy and side effects of combined Chinese drugs and chemotherapy in t...
Abstract Background Extensive-stage small-cell lung cancer (ES-SCLC) is characterized by extensive m...
AbstractObjectiveThe purpose of the study was to assess the efficacy and safety of using Chinese her...
SummaryBackgroundSome patients with non-small-cell lung cancer (NSCLC) respond well to the EGFR tyro...
Copyright © 2014 Weiru Xu et al.This is an open access article distributed under theCreativeCommonsA...
Weigang Dong, Yan Du, Shuping Ma Department of Respiratory and Critical Care Medicine, Tianjin Ches...
Background. Asian ethnicity is associated with a distinct molecular etiology, treatment response, an...
Background and objective It has been proven that gefitinib produces only 10%-20% tumor regression in...
Background and objective Non-small cell lung cancer (NSCLC) stages over IIIb still remain as an intr...
Objective. Novel therapeutics and supportive care improved outcomes for metastatic non-small-cell lu...
Purpose. Many patients with advanced non-small-cell lung cancer (NSCLC) seek help from Chinese herba...
[[abstract]]Objectives: The study aim was to compare the long-term effect of Western medicine and co...
Purpose: Many patients with advanced non-small-cell lung cancer (NSCLC) seek help from Chinese herba...
Lung cancer has become the leading cause of cancer deaths, with nonsmall cell lung cancer (NSCLC) ac...
Objective. This study was designed to evaluate the clinical efficacy of combined traditional Chinese...
Objective: To evaluate the efficacy and side effects of combined Chinese drugs and chemotherapy in t...
Abstract Background Extensive-stage small-cell lung cancer (ES-SCLC) is characterized by extensive m...
AbstractObjectiveThe purpose of the study was to assess the efficacy and safety of using Chinese her...
SummaryBackgroundSome patients with non-small-cell lung cancer (NSCLC) respond well to the EGFR tyro...
Copyright © 2014 Weiru Xu et al.This is an open access article distributed under theCreativeCommonsA...
Weigang Dong, Yan Du, Shuping Ma Department of Respiratory and Critical Care Medicine, Tianjin Ches...
Background. Asian ethnicity is associated with a distinct molecular etiology, treatment response, an...
Background and objective It has been proven that gefitinib produces only 10%-20% tumor regression in...
Background and objective Non-small cell lung cancer (NSCLC) stages over IIIb still remain as an intr...
Objective. Novel therapeutics and supportive care improved outcomes for metastatic non-small-cell lu...